Axsome Therapeutics (AXSM) EPS (Basic) Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -3.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.28% |
| Dec 31, 2025 | 64.29% |
| Sep 30, 2025 | 29.85% |
| Jun 30, 2025 | 41.92% |
| Mar 31, 2025 | 15.28% |
| Dec 31, 2024 | 27.70% |
| Sep 30, 2024 | -1.52% |
| Jun 30, 2024 | -8.44% |
| Mar 31, 2024 | -453.85% |
| Dec 31, 2023 | -48.95% |
| Sep 30, 2023 | -23.36% |
| Jun 30, 2023 | -45.28% |
| Mar 31, 2023 | 75.47% |
| Dec 31, 2022 | -58.89% |
| Sep 30, 2022 | -15.05% |
| Jun 30, 2022 | -23.26% |
| Mar 31, 2022 | -35.90% |
| Dec 31, 2021 | -13.92% |
| Sep 30, 2021 | -52.46% |
| Jun 30, 2021 | -75.51% |
| Mar 31, 2021 | 11.36% |
| Dec 31, 2020 | -11.27% |
| Sep 30, 2020 | -8.93% |
| Jun 30, 2020 | -19.51% |
| Mar 31, 2020 | -175.00% |
| Dec 31, 2019 | -121.88% |
| Sep 30, 2019 | -80.65% |
| Jun 30, 2019 | -28.13% |
| Mar 31, 2019 | -68.42% |
| Dec 31, 2018 | -3.23% |
| Sep 30, 2018 | -14.81% |
| Jun 30, 2018 | -6.67% |
| Mar 31, 2018 | 53.66% |
| Dec 31, 2017 | 18.42% |
| Sep 30, 2017 | 28.95% |
| Jun 30, 2017 | 16.67% |
| Mar 31, 2017 | -32.26% |
| Dec 31, 2016 | -65.22% |
| Sep 30, 2016 | 7.32% |
| Jun 30, 2016 | -89.47% |
| Mar 31, 2016 | -63.16% |